Placing to raise £450,000

Source: RNS
RNS Number : 3229I
Versarien PLC
16 October 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS AMENDED) AS IT FORMS PART OF THE DOMESTIC LAW OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED). UPON PUBLICATION OF THIS ANNOUNCMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

16 October 2024

 

Versarien plc

 

("Versarien" or the "Company")

 

Placing to raise £450,000

 

Versarien plc (AIM: VRS), the advanced materials engineering group, announces it has raised £450,000 (before expenses) by way of a placing (the "Placing") of 1,384,615,385 new ordinary shares in the capital of the Company ("Placing Shares") at a price of 0.0325 pence per share (the "Placing Price").

 

The net proceeds of the Placing will be used to further increase the Company's in-house concrete and mortar testing capabilities and fund external UKAS accredited testing services for 3D construction printed products, as well as for general corporate and working capital purposes.

 

As announced on 14 August 2024, Versarien has signed its first significant 3D construction printing ("3DCP") contract with Building For Humanity CIC, for their flagship Charter Street project, in Accrington, UK.  On-site 3DCP activities will likely start in 2025.  In addition, the Company announced on 1 October 2024 that it had entered into a 12 month commercially funded project with Balfour Beatty, one of the UK's largest construction companies, to develop graphene enhanced 3DCP materials and products.  These projects, and others, demonstrate the traction the Company is experiencing in the construction sector.

 

As previously announced, as at 4 October 2024, the Company had a pipeline of opportunities of £4.7m, of which commercial opportunities represents £1.6m and grants £3.1m.  The net proceeds of the Placing will also help the Company to pursue these opportunities.

 

Admission and Total Voting Rights

 

Application has been made for admission of the Placing Shares to be admitted to trading on AIM ("Admission") on or around 22 October 2024. The Placing Shares will rank pari passu in all respects with the Company's existing ordinary shares. Following Admission, the total number of ordinary shares in the Company in issue will be 3,718,938,737. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

c/o IFC



SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 



IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a manufacturing-light and licensing model.

 

For further information please see: http://www.versarien.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGPGRCUUPCPUA